Chimera Investment (CIM)
(Delayed Data from NYSE)
$15.28 USD
+0.12 (0.79%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $15.27 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$15.28 USD
+0.12 (0.79%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $15.27 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Zacks News
Chimera Investment (CIM) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -54.17% and 17.88%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Red River Bancshares (RRBI) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Red River Bancshares (RRBI) delivered earnings and revenue surprises of 10.94% and 0.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 8% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 29th
by Zacks Equity Research
CIM, CUBI and ILPT have been added to the Zacks Rank #5 (Strong Sell) List on September 29, 2022.
Chimera Investment (CIM) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -16.22% and 12.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Chimera Investment (CIM) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Chimera Investment (CIM) stock based on the movements in the options market lately.
Chimera Investment (CIM) Matches Q1 Earnings Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 0% and 2.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 6.98% and 3.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
First Foundation (FFWM) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
First Foundation (FFWM) delivered earnings and revenue surprises of 27.50% and 1.87%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 5.00% and 11.45%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Annaly (NLY) Q3 Earnings Top Estimate, Book Value & NII Fall
by Zacks Equity Research
Annaly's (NLY) third-quarter results reflect low financing costs, which increase net interest spread. A decline in the average yield on interest-earning assets and book value erosion ail.
Should You Invest in the Invesco KBW High Dividend Yield Financial ETF (KBWD)?
by Zacks Equity Research
Sector ETF report for KBWD
Chimera Investment (CIM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AGNC Investment (AGNC) Tops on Q3 Net Spread and Dollar Roll
by Zacks Equity Research
Lower prepayments and a rise in asset yields aid AGNC Investment's (AGNC) Q3 results. An expansion in book value has been another positive.
Should You Invest in the Invesco KBW High Dividend Yield Financial ETF (KBWD)?
by Zacks Equity Research
Sector ETF report for KBWD
Is Chimera Investment (CIM) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (CIM) Outperforming Other Finance Stocks This Year?
Blackstone Mortgage (BXMT) Announces 10M Share Offering
by Zacks Equity Research
Blackstone Mortgage (BXMT) will use the net proceeds from the 10 million share offering to support additional commercial mortgage loans origination, and other target assets and investments.
Is Chimera Investment (CIM) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (CIM) Outperforming Other Finance Stocks This Year?
Should You Invest in the Invesco KBW High Dividend Yield Financial ETF (KBWD)?
by Zacks Equity Research
Sector ETF report for KBWD
New Residential (NRZ) Closes Caliber Buyout, Hikes Dividend
by Zacks Equity Research
New Residential (NRZ) hikes its third-quarter dividends by 25%, following the acquisition of Caliber, which poses the company to expand mortgage operations.
NexPoint (NREF) Announces Public Offering of Common Stock
by Zacks Equity Research
Net proceeds from NexPoint's (NREF) 2-million share offering is expected to be used for life science and self-storage preferred investments.
What Makes Chimera Investment (CIM) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Chimera Investment (CIM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Chimera Investment (CIM) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (CIM) Outperforming Other Finance Stocks This Year?